Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Aug 21, 2008; 14(31): 4880-4888
Published online Aug 21, 2008. doi: 10.3748/wjg.14.4880
Published online Aug 21, 2008. doi: 10.3748/wjg.14.4880
Figure 4 A: The 5-year recurrence-free survival rate differed significantly (P = 0.
037) and was 51.9% for strong BAMBI expression compared to 79.8% for weak BAMBI expression; B: The impact of the coexpression of BAMBI and β-catenin on the recurrence-free survival with high β-catenin expression, the 5-year recurrence-free survival was 46.9% for strong BAMBI expression compared to 80.8% for weak BAMBI expression (P = 0.035); C: The impact of the coexpression of BAMBI and p53 on the recurrence-free survival with positive p53 expression, the 5-year recurrence-free survival rate was 43.4% for strong BAMBI expression compared to 78.2% for weak BAMBI expression (P = 0.049).
- Citation: Togo N, Ohwada S, Sakurai S, Toya H, Sakamoto I, Yamada T, Nakano T, Muroya K, Takeyoshi I, Nakajima T, Sekiya T, Yamazumi Y, Nakamura T, Akiyama T. Prognostic significance of BMP and activin membrane-bound inhibitor in colorectal cancer. World J Gastroenterol 2008; 14(31): 4880-4888
- URL: https://www.wjgnet.com/1007-9327/full/v14/i31/4880.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.4880